Acumen Fund Invests in Social Enterprise to Stop Counterfeit Drugs

5 ml [Photo by @alviseni] (CC BY-SA 3.0)
_MG_7585.jpg [Photo by Fett] (CC BY-SA 3.0)

Acumen Fund Invests in Social Enterprise to Stop Counterfeit Drugs

The Acumen Fund has invested in a social enterprise called Sproxil, Inc, which uses mobile technology to combat counterfeit medication. The investment will help Sproxil to build sales teams, expand into India and Kenya, and continue to upgrade its technology. The company provides a mobile product authentication solution which enables consumers to verify that the pharmaceutical product they are buying is genuine. The Acumen fund is investing $1.8 million in the innovative business that has the potential to improve millions of lives by combating the multi-billion dollar counterfeit drug market. Directly empowering consumers and giving them the resources they need to make informed pharmaceutical decisions also provides key insights into the dynamics and possibilities of mobile technology as a critical tool for improving lives in the developing world. Sproxil was founded by Dr. Ashifi Gogo, a Ph.D. Innovation Fellow at Dartmouth College who grew up in Ghana.

Watch the Social Entrepreneurship Video Course by Matthew Alberto + Bonuses

Want to Learn More About Social Entrepreneurship?
Learn from Matthew Alberto over 14 weeks about Social Entrepreneurship and how you can make a difference while making money.
BONUSES: 1) Also, get Matthew's business plan that earned his social enterprise $24,000+ in government grants;
2) Get Matthew's bonus video pitch & application form that got him $40,000+ funding from the world's largest incubator
3) Watch Matthew's investor pitch at a Demo Day, which got his social enterprise a valuation of over $1,000,000, plus more funding over $80,000 from a venture accelerator
Click here to watch Matthew Alberto's Social Entrepreneurship Video Course now + Get the Bonuses!